Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 1 |
| Since 2016 (last 10 years) | 1 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Autism Spectrum Disorders | 1 |
| Comorbidity | 1 |
| Drug Therapy | 1 |
| Foreign Countries | 1 |
| Genetic Disorders | 1 |
| Intellectual Disability | 1 |
| Mental Disorders | 1 |
| Patients | 1 |
| Program Effectiveness | 1 |
| Young Adults | 1 |
Source
| International Journal of… | 1 |
Author
| Dønnum, Monica Stolen | 1 |
| Helverschou, Sissel Berge | 1 |
| Kildahl, Arvid Nikolai | 1 |
| Rysstad, Anne Langseth | 1 |
| Skavhaug, Jon Olav | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
| Norway | 1 |
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkRysstad, Anne Langseth; Kildahl, Arvid Nikolai; Skavhaug, Jon Olav; Dønnum, Monica Stolen; Helverschou, Sissel Berge – International Journal of Developmental Disabilities, 2022
Phelan-McDermid syndrome (PHMDS)/22q13.3 deletion syndrome is a rare genetic disorder associated with autism spectrum disorder (ASD), intellectual disability (ID), and bipolar disorder. While numerous cases have been reported describing successful pharmacological treatment of bipolar disorder in PHMDS, there is currently little guidance available…
Descriptors: Genetic Disorders, Autism Spectrum Disorders, Intellectual Disability, Mental Disorders
